Journal Information

Voted One of the 100 Most Influential Journals in Biology & Medicine over the last 100 Years

 by the Special Libraries Association

Selected as a core journal  by the Medical Library Association (Public Health)


Recommend & Share


 • 
 CiteULike

Volume 101, Issue 4 (April 2011)


Accepted on: Jul 22, 2010

Tobacco Harm Reduction and the Evolution of Nicotine Dependence

Mark Parascandola, PhD, MPH
Correspondence should be sent to Mark Parascandola, PhD, MPH, Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, 6130 Executive Blvd, EPN 4032, MSC 7337, Bethesda, MD 20892-7337 (e-mail: ). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints/Eprints” link.

Peer Reviewed



ABSTRACT

In recent years, a renewed debate has developed around the potential for modified tobacco products to play a role in reducing tobacco-related harm. During the 1960s and 1970s medical experts recommended to smokers who could not quit that they switch to cigarettes with lower tar and nicotine content. At the time, survey data suggested that smokers who switched did not compensate for the reduction in nicotine by increasing their intake. However, public health scientists were hindered in their ability to evaluate the population impact of the reduced tar strategy by a limited understanding of nicotine addiction. Smoking dependence was seen as primarily psychological and social, rather than pharmacological or biological, until the late 1970s, when addiction researchers began to apply experimental techniques from other forms of drug abuse to study smoking behavior. This history has important lessons for current discussions about tobacco harm reduction and regulation of nicotine delivery.